Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Biol Psychiatry. 2012 May 2;72(9):752–757. doi: 10.1016/j.biopsych.2012.03.030

Table 2. Medication Information for SZ and BDP.

Participants were on a combination of medications; therefore the N in each class does not indicate the number taking that drug exclusively. Medication data was missing for 3 SZP and 1 BDP. 1 SZ and 1 BDP reported not taking any psychoactive medications.

SZ (N = 38) BDP (N = 31)
No psychoactive medication – N (%) 1 (2.6) 1(3.2)
Antipsychotics (Typical/Atypical) –N (%) 9 (23.7) / 25 (65.8) 0 (0) / 17 (54.8)
Antidepressants – N (%) 16 (42.1) 15 (48.4)
Lithium – N (%) 0 (0) 12 (38.7)
Mood Stabilizers – N (%) 5 (13.2) 16 (51.6)
Anxiolytics & Hypnotics – N (%) 10 (26.3) 16 (51.6)